208 related articles for article (PubMed ID: 37999831)
1. Bowel Urgency in Patients with Ulcerative Colitis and Crohn's Disease: A Cross-Sectional Real-World Survey in Japan.
Wang C; Ishizuka T; Tanaka M; Matsuo K; Knight H; Harvey N; Gillespie-Akar L; Gibble TH
Adv Ther; 2024 Jan; 41(1):431-450. PubMed ID: 37999831
[TBL] [Abstract][Full Text] [Related]
2. Rectal Urgency Among Patients With Ulcerative Colitis or Crohn's Disease: Analyses from a Global Survey.
Ha C; Naegeli AN; Lukanova R; Shan M; Wild R; Hennessy F; Jyothi Kommoju U; Potts Bleakman A; Hunter Gibble T
Crohns Colitis 360; 2023 Oct; 5(4):otad052. PubMed ID: 37928613
[TBL] [Abstract][Full Text] [Related]
3. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
[TBL] [Abstract][Full Text] [Related]
4. Burden of Fatigue Among Patients with Ulcerative Colitis and Crohn's Disease: Results from a Global Survey of Patients and Gastroenterologists.
Regueiro M; Hunter T; Lukanova R; Shan M; Wild R; Knight H; Bannikoppa P; Naegeli AN
Adv Ther; 2023 Feb; 40(2):474-488. PubMed ID: 36370288
[TBL] [Abstract][Full Text] [Related]
5. Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals.
Pittet VEH; Maillard MH; Simonson T; Fournier N; Rogler G; Michetti P;
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2050-2059.e1. PubMed ID: 30471455
[TBL] [Abstract][Full Text] [Related]
6. Construct validity of EQ-5D-5L among patients with inflammatory bowel disease-a study based on real-world data from the Swedish Inflammatory Bowel Disease Registry.
Latteur J; Ernstsson O; Nilsson E; Jäghult S; Heintz E
J Patient Rep Outcomes; 2024 Mar; 8(1):39. PubMed ID: 38536626
[TBL] [Abstract][Full Text] [Related]
7. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.
Irvine EJ; Zhou Q; Thompson AK
Am J Gastroenterol; 1996 Aug; 91(8):1571-8. PubMed ID: 8759664
[TBL] [Abstract][Full Text] [Related]
8. Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries.
Armuzzi A; Hart A; Cappelleri JC; Mammar N; Hur P; Hoskin B; Hennessy F; Milligan G; Dignass A
BMC Gastroenterol; 2023 Jan; 23(1):17. PubMed ID: 36658481
[TBL] [Abstract][Full Text] [Related]
9. Impact of Disease Activity and Inflammatory Bowel Disease Subtype on Quality of Life in Preconception and Pregnant Patients.
Wang G; Tandon P; Rodriguez N; Ambrosio L; Sutton RT; Dieleman LA; Kroeker KI; Huang V
Dig Dis Sci; 2023 Apr; 68(4):1156-1166. PubMed ID: 35930124
[TBL] [Abstract][Full Text] [Related]
10. Assessment of disease specific knowledge and health-related quality of life among United States military veterans with inflammatory bowel disease.
Hou JK; Turkeltaub JA; McCarty Iii TR; El-Serag HB
World J Gastroenterol; 2015 May; 21(19):6001-7. PubMed ID: 26019466
[TBL] [Abstract][Full Text] [Related]
11. Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study).
Abraham B; Eksteen B; Nedd K; Kale H; Patel D; Stephens J; Shelbaya A; Chambers R; Soonasra A
Adv Ther; 2022 May; 39(5):2109-2127. PubMed ID: 35296993
[TBL] [Abstract][Full Text] [Related]
12. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
13. The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe.
Armuzzi A; Tarallo M; Lucas J; Bluff D; Hoskin B; Bargo D; Cappelleri JC; Salese L; daCosta DiBonaventura M
BMC Gastroenterol; 2020 Jan; 20(1):18. PubMed ID: 31964359
[TBL] [Abstract][Full Text] [Related]
14. The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry.
Dalavaye N; Erridge S; Nicholas M; Pillai M; Bapir L; Holvey C; Coomber R; Rucker JJ; Hoare J; Sodergren MH
Expert Rev Gastroenterol Hepatol; 2023 Jan; 17(1):85-98. PubMed ID: 36562418
[TBL] [Abstract][Full Text] [Related]
15. Perceived Quality of Care is Associated with Disease Activity, Quality of Life, Work Productivity, and Gender, but not Disease Phenotype: A Prospective Study in a High-volume IBD Centre.
Gonczi L; Kurti Z; Verdon C; Reinglas J; Kohen R; Morin I; Chavez K; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
J Crohns Colitis; 2019 Sep; 13(9):1138-1147. PubMed ID: 30793162
[TBL] [Abstract][Full Text] [Related]
16. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life of patients with inflammatory bowel disease in Singapore.
Min Ho PY; Hu W; Lee YY; Gao C; Tan YZ; Cheen HH; Wee HL; Lim TG; Ong WC
Intest Res; 2019 Jan; 17(1):107-118. PubMed ID: 30419638
[TBL] [Abstract][Full Text] [Related]
18. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
19. Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease.
Bressler B; Jones J; In TSH; Lan T; Iconaru C; Marshall JK
Adv Ther; 2023 Oct; 40(10):4421-4439. PubMed ID: 37507652
[TBL] [Abstract][Full Text] [Related]
20. Questionnaire Survey for Inflammatory Bowel Disease Patients in Japan; A Web-Based Japan, Crohn's Disease, Ulcerative Colitis, Patients Survey.
Matsumoto T; Imai K; Goda Y; Fujimitsu Y; Kajioka T; Kihara H; Funaki Y; Imaki S; Ueno M
Crohns Colitis 360; 2023 Oct; 5(4):otad069. PubMed ID: 38028953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
